Shopping Cart
- Remove All
- Your shopping cart is currently empty
CD-2394 is a novel synthetic retinoid compound. This compound's treatment reduces the number of cells in the G2M-phase, suggesting a slowdown in cell proliferation. Additionally, normal differentiation is inhibited, while keratin 13 expression is observed in CD-2394-treated samples, a phenomenon not seen in other treated skin samples. This indicates CD-2394 may induce an embryonic differentiation pathway distinct from normal or regenerative differentiation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | CD-2394 is a novel synthetic retinoid compound. This compound's treatment reduces the number of cells in the G2M-phase, suggesting a slowdown in cell proliferation. Additionally, normal differentiation is inhibited, while keratin 13 expression is observed in CD-2394-treated samples, a phenomenon not seen in other treated skin samples. This indicates CD-2394 may induce an embryonic differentiation pathway distinct from normal or regenerative differentiation. |
Alias | CD2394, CD 2394 |
Molecular Weight | 378.46 |
Formula | C24H26O4 |
Cas No. | 170099-89-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.